Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Cosmetics Reform Legislation (no bill number) Cosmetic Safety Enhancement Act of 2019 (H.R. 5279)
Cosmetics Reform Legislation (no bill number); Cosmetic Safety Enhancement Act of 2019 (H.R. 5279); Risk assessment of fragrance allergens; Issues relating to the MuST testing of sunscreen ingredients
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2020 · third_quarter · Q3
SHOP SAFE Act of 2020 (H.R. 6058)
Cosmetics Reform Legislation (no bill number) Cosmetic Safety Enhancement Act of 2019 (H.R. 5279)
Filing targets: HOUSE OF REPRESENTATIVES
Source: Senate LDA
SHOP SAFE Act of 2020 (H.R. 6058)
Cosmetics Reform Legislation (no bill number); Cosmetic Safety Enhancement Act of 2019 (H.R. 5279); Risk assessment of fragrance allergens; Issues relating to the MuST testing of sunscreen ingredients
2020 · first_quarter · Q1
Risks of counterfeit branded merchandise being sold on internet platforms (no bill number); Bad-faith and fraudulent trademark applications filed by internationally-based entities
Cosmetics Reform Legislation (no bill number); Cosmetic Safety Enhancement Act of 2019 (H.R. 5279); Risk assessment of fragrance allergens; Issues relating to the MuST testing of sunscreen ingredients
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Q4
Cosmetics Reform Legislation (no bill number); Cosmetic Safety Enhancement Act of 2019 (H.R. 5279); Risk assessment of fragrance allergens; Issues relating to the MuST testing of sunscreen ingredients
Risks of counterfeit branded merchandise being sold on internet platforms (no bill number); Bad-faith and fraudulent trademark applications filed by internationally-based entities
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Patent & Trademark Office (PTO)
2019 · third_quarter · Q3
Cosmetics Reform Legislation (no bill number); Risk assessment of fragrance allergens
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES